Skip to content
★ Sign in to follow
YD

Yu De-Chao Michael

Executive
Insider activity · 24 months0 buys1 saleCumulative net flow
Total declarations
15
Company
1
▲ Purchases (4 ops.)
—
▼ Sales (5 ops.)
€339.3M

Latest filing published 13 May 2026 for Innovent Biologics, Inc., €13.1M.

Filing timeline

BuySale
Yu De-Chao Michael

Insider track record

Disclosed buys
4
Disclosed sells
5
Signal history

No signal scores available.

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Yu De-Chao Michael: trading record in brief

Yu De-Chao Michael (chief executive) discloses dealings in Innovent Biologics, Inc. to HKEX. In total, 15 filings cover trades dated from 31 October 2018 to 11 May 2026.

In open-market terms, that means 4 purchases on one side and 5 sales worth €339.3M on the other. The totals exclude 6 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at 1 purchase and 1 sale.

The newest entry dates from 13 May 2026: an open-market sale of €13.1M, in Innovent Biologics, Inc. The clock since the last published purchase (2 April 2026) now reads 221 days. Typically, a trade is published a median of 5 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from HKEX disclosures alone and does not predict where the share price will go.

Companies and markets linked to Yu De-Chao Michael

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total

15 of 15 declarations